Predict your next investment

HEALTHCARE | Biotechnology

See what CB Insights has to offer


Series D | Alive

Total Raised


Last Raised

$2.36M | 26 yrs ago

About BioTransplant

BioTransplant (BT) acquired Eligix, a developer of therapy for patients receiving bone marrow (or stem cell) transplants and related procedures to treat leukemia, lymphoma, and other diseases,

BioTransplant Headquarter Location

101 Washington Street Suite 101 Foxborough, MA 02035 Suite 101

Foxborough, Massachusetts, 02035,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing BioTransplant

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

BioTransplant is included in 1 Expert Collection, including Regenerative Medicine.


Regenerative Medicine

1,818 items

Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.